UMN Medical School Students Join National Resource Stewardship Cohort to Advocate for High-Value Care

The high cost of medical care remains a frequent criticism of the United States healthcare system. One way of combating that cost, says the U.S. STARS (Students and Trainees Advocating for Resource Stewardship) program, is reducing “low-value” care – unnecessary or ineffective tests and treatments that add cost while contributing little to a patient’s eventual health outcomes.

For University of Minnesota Medical School first-year students Lauren Rose and Luke Klugherz, joining the U.S. STARS cohort during its inaugural year was an exciting opportunity to make an impact on their field.

“My interest was sparked when I spoke with a physician about strep throat. He talked about how he didn’t use antibiotics to treat strep because left untreated it would go away on its own. This made me think  what else are we doing that causes more harm than good?” says Klugherz. “Simply starting a conversation between students could make a huge impact.”

According to the Choosing Wisely STARS program website, the initiative determines high-value care based on four criteria, supporting care that is “supported by evidence, not duplicative of other tests or procedures already received, free from harm and truly necessary.” 

The cohort, which brings together 50 students from around the country representing 25 different universities, is based on a model that originated in Canada in 2015. For Klugherz and Rose, it’s a fitting response to a well-known problem.

“As medical students with the current healthcare climate we constantly hear about the broken system we’re going into, and how medicine is going to have to change in order to fix the issue,” says Rose. “This work is important and it seems like a tangible way that I can help to fix the problem.” 

Learn more about the U.S. Stars Program.

 

Share this post

Related News

  • Transplant Expert Becomes Transplant Minnesotan

    Andrew Adams, MD, PhD, has joined the Department of Surgery as a professor and as chief of the Division of Transplantation at both M Health Fairview University of Minnesota hospitals. He brings $11.7 million in funding from the National Institutes of Health focused on developing novel therapies to improve outcomes for transplant patients.

  • Study Analyzes if Telemedicine is Efficacious in Treating Opioid Use Disorder

    Federal and state agencies have temporarily allowed unprecedented flexibility for the use of telemedicine, including audio-only visits, for encounters where opioid use disorder (OUD) medications are prescribed. Cuong Pham, MD, an assistant professor in the Department of Medicine, is analyzing telemedicine’s efficacy for patients with OUD during COVID-19.

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”